局部晚期鼻咽癌IMRT下视神经及视交叉耐受剂量探讨

doi:10.3760/cma.j.issn.1004-4221.2017.11.002

Abstract
Figure/Table
References()
Related Citation (15)
Read Tracking
Download Tracking

Download: PDF (1120 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS) Supporting Info

Abstract

Objective To investigate the tolerated dose of the optic nerves and chiasm in patients with locally advanced nasopharyngeal carcinoma (NPC) treated with intensity-modulated radiotherapy (IMRT). Methods A retrospective analysis was performed on dose characteristics and the incidence of radiation optic neuropathy in 108 patients with locally advanced NPC treated with IMRT at D2>55 Gy in the optic nerves and chiasm in our hospital between May 2009 and December 2013. The Common Terminology Criteria for Adverse Events (CTCAE) Version 3.0 grading criteria were used for evaluating adverse reactions of the optic nerves and optic chiasm. A logistic regression analysis was performed to assess the risk factors for the development of radiation-induced optic neuropathy (RION). Resutls No patient had severe RION (grade 3-5),although 7 of the 108 patients had mild optic nerve disorder (grade 1-2). No patient-or treatment-related factors were found to be associated with the development of RION (P>0.05). With a median follow-up of 46 months (range,13-91 months),the 3-year estimated overall survival,local recurrence-free survival,and distant metastasis-free survival rates were 90.0%,94.5%,and 86.4%,respectively. Conclutions The dose constraint of<55 Gy derived for optic nerves and chiasm from conventional radiotherapy does not seem to apply to IMRT. For advanced NPC patients treated with IMRT,the dose constraints of optic nerves and chiasm might be relaxed in order to improve target coverage.

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Xu Meng
	Huang Lulu
	Hu Kai
	Wang Rensheng

Key words： Radiation induced optic neuropathy Nasopharyngeal neoplasms/intensity-modulated radiotherapy Dose constraints

Received: 02 May 2017

Corresponding Authors: Wang Rensheng,Email:13807806008@163.com

Cite this article:

Xu Meng,Huang Lulu,Hu Kai et al. Dose constraints of optic nerves and chiasm in locally advanced nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy[J]. Chinese Journal of Radiation Oncology, 2017, 26(11): 1248-1252.

URL:

http://journal12.magtechjournal.com/Jweb_fszlx/EN/10.3760/cma.j.issn.1004-4221.2017.11.002 OR http://journal12.magtechjournal.com/Jweb_fszlx/EN/Y2017/V26/I11/1248

[1] 张燕,李红阳,彭春霞,等.放射性视神经病变的诊疗特征[J].国际眼科杂志,2014,14(6):1095-1099.DOI:10.3980/j.issn.1672-5123.2014.06.31.
Zhang y,Li HY,Peng CX,et al. Diagnosis and treatment characteristics of radioactive optic neuropathy[J].Int Eye Sci,2014,14(6):1095-1099.DOI:10.3980/j.issn.1672-5123.2014.06.31.
[2] 刘茹,邝国平,谢丽莲,等.鼻咽癌放疗术后眼部并发症的临床分析[J].国际眼科杂志,2015,15(9):1671-1674.DOI:10.3980/j.issn.1672-5123.2015.9.53.
Liu R,Kuang GP,Xie LL,et al. Clinical study on ocular complications subsequent to radiotherapy of nasopharyngeal carcinoma[J].Int Eye Sci,2015,15(9):1671-1674.DOI:10.3980/j.issn.1672-5123.2015.9.53.
[3] Lee N,Harris J,Garden A S,et al. Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma:Radiation Therapy Oncology Group Phase Ⅱ Trial 0225[J].J Clin Oncol,2009,27(22):3684-3690.DOI:10.1200/JCO.2008.19.9109.
[4] Mayo C,Martel MK,Marks L B,et al. Radiation dose-volume effects of optic nerves and chiasm.[J].Int J Radiat Oncol Biol Phys,2010,76(3):S28-S35.DOI:10.1016/j.ijrobp.2009.07.1753.
[5] Listed N.Prescribing,recording,and reporting photon-Beam Intensity-Modulated Radiation Therapy (IMRT):contents[J].J ICRU,2010,10(1):1-106.
[6] 潘东艳,赵世红,孙伟峰,等.放射性视神经病变诊疗进展[J].中国实用眼科杂志,2015,33(3):224-226.
Pan DY,Zhao SH,Sun WF,et al. Progress in diagnosis and treatment of radiation optic neuropathy[J].Chin J Pract Ophthalmol,2015,33(3):224-226.
[7] Van Den Bergh ACM,Dullaart RPF,Hoving MA,et al. Radiation optic neuropathy after external beam radiation therapy for acromegaly[J].Radioth Oncol,2003,68(2):95-100.DOI:10.1016/S0167-8140(03)00202-0.
[8] Parsons JT,Bova FJ,Fitzgerald CR,et al. Radiation optic neuropathy after megavoltage external-beam irradiation:analysis of time-dose factors[J].Int J Radiat Oncol Biol Phys,1994,30(4):755-763.DOI:10.1016/0360-3016(94)90346-8.
[9] Jiang GL,Tucker SL,Guttenberger R,et al. Radiation-induced injury to the visual pathway[J].Radioth Oncol,1994,30(1):17-25.DOI:10.1016/0167-8140(94)90005-1.
[10] Daly ME,Chen AM,Bucci MK,et al. Intensity-modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses[J].Int J Radiat Oncol Biol Phys,2007,67(1):151-157.DOI:10.1016/j.ijrobp.2006.07.1389.
[11] Martel MK,Sandler HM,Cornblath WT,et al. Dose-volume complication analysis for visual pathway structures of patients with advanced paranasal sinus tumors[J].Int J Radiat Oncol Biol Phys,1997,38(2):273-284.DOI:10.1016/S0360-3016(97)00029-1.
[12] 管西寅.放射引起的视神经病变基础与临床研究[D].上海:复旦大学,2011.
Guan XY.Basic and clinical study of radiation induced optic neuropathy[D].Shanghai:Fudan university,2011.
[13] Bhandare N,Monroe AT,Morris CG,et al. Does altered fractionation influence the risk of radiation-induced optic neuropathy?[J].Int J Radiat Oncol Biol Phys,2005,62(4):1070-1077.DOI:10.1016/j.ijrobp.2004.12.009.
[14] Zhao ZY,Lan YQ,Bai SM,et al. Late-onset radiation-induced optic neuropathy after radiotherapy for nasopharyngeal carcinoma[J].J Clin Neurosc,2013,20(5):702-706.DOI:10.1016/j.jocn.2012.05.034.
[15] 肖光莉,王卫华,丘熹彬,等.176例鼻咽癌IMRT晚期不良反应分析[J].中华放射肿瘤学杂志,2013,22(1):42-44.DOI:10.3760/cma.j.issn.1004-4221.2013.01.013.
Xiao GL,Wang WH,Qiu XB,et al. Analysis of late toxicities after intensity-modulated radiotherapy in 176 patients with nasopharyngeal carcinoma[J].Chin J Radiat Oncol,2013,22(1):42-44.DOI:10.3760/cma.j.issn.1004-4221.2013.01.013.
[16] Hoppe BS,Stegman LD,Zelefsky MJ,et al. Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting—the MSKCC experience[J].Int J Radiat Oncol Biol Phys,2007,67(3):691-702.DOI:10.1016/j.ijrobp.2006.09.023.
[17] Seregard S,Pelayes DE,Singh AD.Radiation therapy:posterior segment complications[J].Dev Ophthalmol,2013,52:114-123.DOI:10.1159/000351088.
[18] Kumre D,Jeswani V,Benurwar S,et al. Role of total dose and hyperfractionation in reducing risk of radiation-induced optic neuropathy[J].Oman J Ophthalmol,2015,8(1):75-76.DOI:10.4103/0974-620X.149901.
[19] Wang W,Yang H,Guo L,et al. Radiation-induced optic neuropathy following external beam radiation therapy for nasopharyngeal carcinoma:A retrospective case-control study[J].Mol Clin Oncol,2016,4(5):868-872.DOI:10.3892/mco.2016.787.
[20] Ferguson I,Huecker J,Huang J,et al. Risk factors for radiation-induced optic neuropathy:a case-control study[J].Clin Exp Ophthalmol,2017,45(6):592-597.DOI:10.1111/ceo.12927.
[21] Farzin M,Molls M,Kampfer S,et al. Optic toxicity in radiation treatment of meningioma:a retrospective study in 213 patients[J].J Neuro-Oncol,2016,127(3):597-606.DOI:10.1007/s11060-016-2071-7.
[22] 潘燚,胡伟汉,高艺,等.鼻咽癌放疗后视野与视觉诱发电位的改变[J].癌症,2005,24(6):722-726.DOI:10.3321/j.issn:1000-467X.2005.06.019.
Pan Y,Hu WH,Gao Y,et al. Changes of visual field and visual evoked potential in nasopharyngeal carcinoma patients after radiotherapy[J].Chin J Cancer,2005,24(6):722-726.DOI:10.3321/j.issn:1000-467X.2005.06.019.